Cabio Biotech Wuhan Co Ltd (688089) — Capital Reinvestment Ratio
Cabio Biotech Wuhan Co Ltd (688089) has a Capital Reinvestment Ratio of 0.97x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥56.10 Million) in capital expenditures (CN¥54.25 Million). See Cabio Biotech Wuhan Co Ltd (688089) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Cabio Biotech Wuhan Co Ltd Capital Reinvestment Ratio (2013–2024)
This chart tracks Cabio Biotech Wuhan Co Ltd's Capital Reinvestment Ratio across 12 annual periods. Check how aggressively does Cabio Biotech Wuhan Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Cabio Biotech Wuhan Co Ltd (2013–2024)
Year-by-year Capital Reinvestment Ratio for Cabio Biotech Wuhan Co Ltd from 2013 to 2024. For live market cap and broader valuation context, see Cabio Biotech Wuhan Co Ltd (688089) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.22x | CN¥173.04 Million | CN¥211.60 Million | ▼ -71.7% |
| 2023 | 4.32x | CN¥68.89 Million | CN¥297.68 Million | ▲ +205.6% |
| 2022 | 1.41x | CN¥176.40 Million | CN¥249.47 Million | ▼ -15.8% |
| 2021 | 1.68x | CN¥103.29 Million | CN¥173.43 Million | ▲ +640.0% |
| 2020 | 0.23x | CN¥145.88 Million | CN¥33.10 Million | ▲ +28.6% |
| 2019 | 0.18x | CN¥131.95 Million | CN¥23.27 Million | ▲ +51.7% |
| 2018 | 0.12x | CN¥106.16 Million | CN¥12.34 Million | ▼ -49.5% |
| 2017 | 0.23x | CN¥100.66 Million | CN¥23.16 Million | ▼ -11.2% |
| 2016 | 0.26x | CN¥62.53 Million | CN¥16.21 Million | ▼ -46.6% |
| 2015 | 0.49x | CN¥44.58 Million | CN¥21.65 Million | ▲ +7.7% |
| 2014 | 0.45x | CN¥46.34 Million | CN¥20.90 Million | ▲ +11.1% |
| 2013 | 0.41x | CN¥39.48 Million | CN¥16.03 Million | — |